CN1022765C - Preparation method of cell variety mycomycin of new antibiotic - Google Patents
Preparation method of cell variety mycomycin of new antibiotic Download PDFInfo
- Publication number
- CN1022765C CN1022765C CN86100600.3A CN86100600A CN1022765C CN 1022765 C CN1022765 C CN 1022765C CN 86100600 A CN86100600 A CN 86100600A CN 1022765 C CN1022765 C CN 1022765C
- Authority
- CN
- China
- Prior art keywords
- antibiotic
- mycomycin
- new antibiotic
- streptomyces
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
本发明涉及新抗生素胞变菌素(Blebomycin,代号SR-44B)及其制备方法。本发明所述的抗生素是由链霉菌属的抗生素胞变菌素生产菌的培养液中分离而得,是一种未见文献报道的新抗生素。本抗生素胞变菌素与本申请相应的日本专利申请中的Blebomycin(代号RS-44B)是同一物质。The invention relates to a new antibiotic Blebomycin (code name SR-44B) and a preparation method thereof. The antibiotic described in the present invention is obtained by separating from the culture solution of the antibiotic cytomacin-producing bacteria of the genus Streptomyces, and is a new antibiotic that has not been reported in literature. The antibiotic Cytovaricin is the same substance as Blebomycin (code name RS-44B) in the corresponding Japanese patent application of the present application.
近年来,抗生素不仅在医药方面,而且在农药方面也正在被广泛应用。本发明者为了寻找出比以往更为有效的新抗生素,从多种土壤中分离出微生物来培养抗生素。然后对这些抗生素分别进行精制、鉴定和开发应用。In recent years, antibiotics are being widely used not only in medicine but also in agricultural chemicals. In order to search for new antibiotics that are more effective than before, the present inventors isolated microorganisms from various soils and cultivated antibiotics. Then these antibiotics were refined, identified and developed.
其结果是本发明者首先从链霉素SR-44(streptomyces sp·SR-44)的培养物中成功地分离和精制出新抗生素制黄肝菌素。经过进一步的研究,又从上述SR-44菌株的培养物中成功地分离并精制出新抗生素胞变菌素。胞变菌素在理化及生物上均具有与制黄肝菌素完全不同的性质。As a result, the inventors first successfully isolated and refined new antibiotic flavoparin from the culture of streptomyces SR-44 (streptomyces sp·SR-44). After further research, a new antibiotic, cytotaxin, was successfully isolated and refined from the culture of the above-mentioned SR-44 strain. Cytostatin has completely different properties from aflatarin in physicochemical and biological aspects.
本发明的目的在于提供一种新抗生素,并提供一种从链霉菌属的微生物中分离、制取该抗生素的方法。The object of the present invention is to provide a new antibiotic and a method for isolating and preparing the antibiotic from the microorganisms of the genus Streptomyces.
以下对本发明进行详细的说明。The present invention will be described in detail below.
使用的微生物microorganisms used
用来生产本发明所述的抗生素胞变菌素的微生物是一种属于链霉菌属的菌种,其具有生产抗生素胞变菌素的能力。The microorganism used to produce the antibiotic mutamycin of the present invention is a strain belonging to the genus Streptomyces, which has the ability to produce the antibiotic mutamycin.
链霉菌SP·SR-44(Streptomyces SP·SR-44)(中国微生物菌种保藏管理委员会普通微生物保藏中心的保藏号CGMCC-0092)(以下简称为“SR-44菌株”)就是其中一例。Streptomyces SP·SR-44 (Streptomyces SP·SR-44) (collection number CGMCC-0092 of the General Microorganism Collection Center of China Microbiological Culture Collection Management Committee) (hereinafter referred to as "SR-44 strain") is one example.
该微生物具有上述特性,适于生产本发明所述的抗生素SR-44B,因而能有效地使用于本发明所述的制备方法中。The microorganism has the above-mentioned characteristics and is suitable for producing the antibiotic SR-44B of the present invention, so it can be effectively used in the preparation method of the present invention.
同时,上述“SR-44菌株”的自然及其人工变异菌株也均属于链霉菌属的菌种。凡具有生产后述抗生素胞变菌素能力的微生物均可应用本发明所述的方法。At the same time, the natural and artificially mutated strains of the above-mentioned "SR-44 strain" also belong to the strains of the genus Streptomyces. The method of the present invention can be applied to any microorganism that has the ability to produce the antibiotic cytastatin mentioned later.
上述“SR-44菌株”是从中国江苏省的土壤中分离而得,其具有下述性质:The above "SR-44 strain" was isolated from soil in Jiangsu Province, China, and has the following properties:
1.形态特征:1. Morphological characteristics:
在用含有葡萄糖、酵母浸膏的菌体分析用培养基上培养本菌株“SR-44菌株”,然后进行菌体分离干燥,再用6N盐酸在110℃、加热水解20小时。用纸层析法检测细胞壁的氨基酸组分时,可以发现L、L-二氨基庚二酸。This strain "SR-44 strain" was cultivated on the cell analysis medium containing glucose and yeast extract, and then the cells were separated and dried, and then heated and hydrolyzed with 6N hydrochloric acid at 110°C for 20 hours. L, L-diaminopimelic acid can be found when the amino acid composition of the cell wall is detected by paper chromatography.
此外,在琼脂平板上生长的气生菌丝呈现出螺旋状,可以看出这种螺旋状菌丝是由数十个孢子所组成,但是却看不到孢子囊和运动性的孢子。In addition, the aerial hyphae grown on the agar plate showed a spiral shape, and it could be seen that the spiral hyphae was composed of dozens of spores, but no sporangia and motile spores could be seen.
以上可以说明,本菌株属于链霉菌属。孢子的形态呈园柱状、表面平滑。It can be explained above that this bacterial strain belongs to the genus Streptomyces. The spores are cylindrical in shape and smooth in surface.
2.在各种培养基上的生长状态(于27℃培养三周,颜色按照“颜色名称描述词典”(Descriptive color names diotionary)记述。2. Growth state on various media (cultivated at 27°C for three weeks, and the color is described in the "Descriptive color names diotionary").
(1)蔗糖硝酸盐琼脂培养基(1) Sucrose nitrate agar medium
生长 不生长grow not grow
(2)葡萄糖-天冬酰胺琼脂培养基(2) Glucose-asparagine agar medium
生长 不生长grow not grow
气生菌丝 微量 b灰乳色(oyster white)Aerial mycelium trace b gray cream (oyster white)
基内 b灰乳色(oyster white)base b gray cream (oyster white)
色素 无Pigment No
(3)甘油-天冬酰胺琼脂培养基(3) Glycerol-Asparagine Agar Medium
生长 普通growth normal
气生菌丝 微量 b灰乳色(oyster white)Aerial mycelium trace b gray cream (oyster white)
基内 b灰乳色(oyster white)base b gray cream (oyster white)
色素 无Pigment No
(4)淀粉-无机盐琼脂培养基(4) Starch-inorganic salt agar medium
生长 良好growing well
气生菌丝 多量 2ge柏氏色(Bergey)Aerial mycelia Large quantity 2ge Bergey
基内 2ie淡芥色(light mustard)base 2ie light mustard (light mustard)
色素 无Pigment No
(5)酪氨酸琼脂培养基(5) Tyrosine agar medium
生长 良好growing well
气生菌丝 多量 3dc自然色(natural)Aerial mycelium Large amount 3dc natural color (natural)
基内 2le芥色(mustard)Base 2le mustard (mustard)
色素 2ea亮黄色(light maize)Pigment 2ea bright yellow (light maize)
(6)营养琼脂培养基(6) Nutrient agar medium
生长 良好growing well
气生菌丝 无Aerial mycelia None
基内 1 1/2 Ca乳色(cream)
色素 无Pigment No
(7)酵母-麦芽琼脂培养基(7) Yeast-malt agar medium
生长 良好growing well
气生菌丝 多量 5fe灰色(ash)Aerial mycelia Large amount 5fe gray (ash)
基内 2lg芥黄褐色(mustard tan)Base 2 lg mustard tan (mustard tan)
色素 无Pigment No
(8)麦片琼脂培养基(8) Oatmeal agar medium
生长 不良poor growth
气生菌丝 无Aerial mycelia None
基内 不明Base Unknown
色素 无Pigment No
(9)胨-酵母-铁琼脂培养基(9) Peptone-yeast-iron agar medium
生长 良好growing well
气生菌丝 无Aerial mycelia None
基内 1 1/2 ea淡黄色(light yellow)base 1 1/2 ea light yellow
色素 无Pigment No
3.碳源的利用性(普戈琼脂培养基)3. Utilization of carbon source (Pugo agar medium)
L-阿拉伯糖 -L-Arabinose -
D-木糖 +D-xylose +
D-葡萄糖 +D-glucose +
D-果糖 -D-Fructose -
蔗糖 -Sucrose -
肌醇 -Inositol -
L-鼠李糖 -L-rhamnose -
棉子糖 -Raffinose -
D-甘露醇 -D-Mannitol -
+……生长 -……不生长+...grows -...does not grow
4.其它生理性质4. Other physiological properties
(1)合适温度 25~30℃(1) Suitable temperature 25~30℃
(2)明胶的液化 液化(2) Liquefaction of gelatin Liquefaction
(葡萄糖-胨-明胶培养基)(glucose-peptone-gelatin medium)
(3)淀粉水解 水解(3) Starch hydrolysis Hydrolysis
(淀粉-无机盐琼脂培养基)(starch-inorganic salt agar medium)
(4)脱脂乳的凝固 凝固(4) Coagulation of skim milk Coagulation
(5)脱脂乳的液化 液化(5) Liquefaction of skim milk Liquefaction
(6)黑色素的生成(6) Production of melanin
(酪氨酸琼脂培养基) 不生成(Tyrosine agar medium) Does not generate
(胨-酵母铁琼脂培养基) 不生成(Peptone-Yeast Iron Agar Medium) Does not generate
具有上述各性质的链霉菌属菌种按柏氏细菌学鉴定手册第八版(Bergey′s Manual of Determinative Bacteriology 8 th ed.)分类法,本菌种应属于WISIC-ISM群,从色调、孢子形态来看,最近缘可可链霉菌。由此可以推断本菌种属可可链霉菌或其极近缘菌。Streptomyces species with the above properties are classified according to Bergey's Manual of Determinative Bacteriology 8 th ed. (Bergey's Manual of Determinative Bacteriology 8 th ed.), and this strain should belong to the WISIC-ISM group. Look, the closest relative is Streptomyces cocoa. It can be inferred that this strain belongs to Streptomyces cocoa or its close relatives.
SR-44菌株的培养及胞变菌素的制取和提纯Cultivation of SR-44 Strain and Preparation and Purification of Cytovaricin
用链霉菌属的上述抗生素生产菌,通过常规的抗生素生产方法,可以培养“SR-44菌株”并制得本发明所述的抗生素胞变菌素,培养方式既可为液体培养也可为固体培养。但为了有利于工业性生产时的培养,宜将上述生产菌的孢子悬浮液或培养液接种到培养基上并进行通气搅拌培养。Using the above-mentioned antibiotic-producing bacteria of the genus Streptomyces, the "SR-44 strain" can be cultivated by conventional antibiotic production methods to produce the antibiotic cytastatin of the present invention, and the culture method can be either liquid culture or solid nourish. However, in order to facilitate the cultivation during industrial production, it is advisable to inoculate the spore suspension or culture solution of the above-mentioned production bacteria on the medium and carry out aeration and agitation cultivation.
对培养基中的营养源并无特殊的规定,可含有常用于微生物培养的碳源,氮源及其它营养源。其中碳源可为淀粉、糊精、甘油、葡萄糖、蔗糖、乳糖、肌醇、甘露醇等,氮源可为胨、大豆粉、肉膏、米糠、麦皮、尿素、玉米浆、铵盐、硝酸盐,以及其它有机或无机含氮化合物。对于其它营养源来讲,可适当添加一些无机盐类,例如食盐、磷酸盐类 及钾、钙、锌、锰、铁之类的金属盐,必要时也可添加些动、植、矿物油等作为消泡剂。There is no special regulation on the nutrient source in the culture medium, and it may contain carbon source, nitrogen source and other nutrient sources commonly used in microorganism cultivation. Among them, the carbon source can be starch, dextrin, glycerin, glucose, sucrose, lactose, inositol, mannitol, etc., and the nitrogen source can be peptone, soybean powder, meat extract, rice bran, wheat bran, urea, corn steep liquor, ammonium salt, Nitrates, and other organic or inorganic nitrogen-containing compounds. For other nutrient sources, some inorganic salts, such as table salt and phosphate, can be added appropriately And potassium, calcium, zinc, manganese, iron and other metal salts, if necessary, some animals, plants, mineral oils, etc. can also be added as defoamers.
对培养时的温度、时间等培养条件并无严格的限制,以适于使用菌的发育为准,并以选择胞变菌素产量最高的条件为好。例如,培养基的PH范围可为4~9,以接近中性为好。培养温度、搅拌条件等均应根据所使用菌株的种类及外部条件等进行适当的调节,以获得最好的效果。There are no strict restrictions on the culture conditions such as temperature and time during the culture, whichever is suitable for the development of the bacteria used, and it is better to choose the conditions with the highest mutamycin production. For example, the pH range of the medium can be 4-9, preferably close to neutral. The culture temperature and stirring conditions should be properly adjusted according to the type of strain used and external conditions to obtain the best results.
由上述所得的培养物出发,通过一些适当的方法就能制得胞变菌素这是些常用于提取代谢产物的常规方法。例如,可利用胞变菌素与不纯物在溶解度、离子结合力、吸附亲和力及分子量等方面的差别进行提取,具体地讲,胞变菌素大部分存在于培养滤液中。将培养液调整到偏酸性,譬如调整到PH4.0,再用醋酸乙酯之类的有机溶剂进行提取,所得的浓缩油状物通过吸附层析、硅胶层析、液相层析、离子交换层析、凝胶层析等组合精制后,即可得到含有胞变菌素及其它活性成分的组份。例如,将油状物进行硅胶层析后在氯仿-甲醇中展开得到活性组份。然后通过高速液相层析〔例如,充填剂选用Nucleosi15C18,展开剂为甲醇-水(8∶2)〕收集SR-44B的活性部分,然后用甲醇进行重结晶,即可得到胞变菌素的无色结晶。Starting from the culture obtained above, cytotaxin can be produced by some appropriate methods. These are some conventional methods commonly used to extract metabolites. For example, the difference in solubility, ion binding capacity, adsorption affinity and molecular weight between mutatin and impurities can be used for extraction. Specifically, mutatin is mostly present in the culture filtrate. Adjust the culture medium to be slightly acidic, such as to pH 4.0, and then extract it with an organic solvent such as ethyl acetate. After combined purification by analysis, gel chromatography, etc., the components containing mutatin and other active ingredients can be obtained. For example, the oily substance is subjected to silica gel chromatography followed by development in chloroform-methanol to obtain the active component. Then collect the active part of SR-44B by high-speed liquid chromatography [for example, Nucleosi 15C 18 is selected as the filling agent, and methanol-water (8:2) is the developing solvent], and then recrystallized with methanol to obtain cytotaxin of colorless crystals.
如此所制取的新抗生素胞变菌素具有下述理化性质及生物性质。The thus-prepared new antibiotic cytaxin has the following physicochemical and biological properties.
抗生素胞变菌素的理化性质及生物性质Physicochemical and Biological Properties of the Antibiotic Cytovaricin
形状:无色结晶Shape: colorless crystal
熔点:157~160℃Melting point: 157~160℃
元素分析:碳58.14%、氢6.77%、氮10.70%、氧24.13%Elemental analysis: carbon 58.14%, hydrogen 6.77%, nitrogen 10.70%, oxygen 24.13%
分子量:895(按FD质谱)Molecular weight: 895 (according to FD mass spectrum)
比旋度:〔α〕25 D-76°(C=0.5甲醇)Specific rotation: [α] 25 D -76° (C = 0.5 methanol)
紫外吸收光谱:λ (E1% 1cm)230(90)、265肩峰(7.3)、268肩峰(8.1)、274(8.5)、282(7.1)(参照图1)UV absorption spectrum: λ (E 1% 1cm ) 230 (90), 265 shoulder (7.3), 268 shoulder (8.1), 274 (8.5), 282 (7.1) (see Figure 1)
红外吸收光谱:νkBr maxcm-13300、2950、1725、1630、1525、1500、1450、1400、1295、1245、1195、1080、1050、1020、825、745、695(参照图2)Infrared absorption spectrum: ν kBr max cm -1 3300, 2950, 1725, 1630, 1525, 1500, 1450, 1400, 1295, 1245, 1195, 1080, 1050, 1020, 825, 745, 695 (see Figure 2)
酸性水解:酸性水解可得丝氨酸、苏氨酸、甘氨酸、酪氨酸及其他氨基酸。Acid hydrolysis: acid hydrolysis can obtain serine, threonine, glycine, tyrosine and other amino acids.
显色反应:与Dragendolf及Rydon·Smith呈阳性反应Color reaction: positive reaction with Dragendolf and Rydon Smith
溶解性:易溶于甲醇、醋酸乙酯、氯仿,难溶于水、戊烷、己烷、苯。Solubility: easily soluble in methanol, ethyl acetate, chloroform, insoluble in water, pentane, hexane, benzene.
薄层分析:(美国Merck公司制造的0.25mm硅薄层板)Thin-layer analysis: (0.25mm silicon thin-layer board manufactured by Merck, USA)
溶剂 Rf值Solvent Rf value
氯仿∶甲醇=10∶1 0.57Chloroform: Methanol = 10:1 0.57
醋酸乙酯∶苯=4∶1 0.13Ethyl acetate: benzene = 4: 1 0.13
抗菌谱:采用通常的琼脂平板稀释法,求出最低抑制浓度(MIC)。(真菌使用马铃薯、蔗糖琼脂培养基,细菌使用肉汤琼脂培养基。)结果,胞变菌素对黄单胞菌(Xantho-monas)属的细菌显示出特异的强生长抑制作用,而对通常的细菌、霉菌却几乎无生长抑制作用。Antibacterial Spectrum: Use the usual agar plate dilution method to obtain the minimum inhibitory concentration (MIC). (Potato-sucrose agar medium was used for fungi, and broth agar medium was used for bacteria.) As a result, varicosin showed a strong growth-inhibitory effect specific to bacteria of the genus Xantho-monas, whereas normal Bacteria and molds have almost no growth inhibitory effect.
测试菌 MIC(mcg/ml)Test bacteria MIC (mcg/ml)
水稻黄单胞菌 2Xanthomonas oryzae 2
(Xanthomonas oryzae)(Xanthomonas oryzae)
柑枯黄单胞菌 4Xanthomonas citrus 4
(Xanthomonas citri)(Xanthomonas citri)
大肠埃希氏菌 >1000Escherichia coli >1000
(Escherichia coli)(Escherichia coli)
鼠伤寒沙门氏杆菌 >1000Salmonella typhimurium >1000
(Salmonella typhimurium)(Salmonella typhimurium)
金色葡萄球菌209P >1000Staphylococcus aureus 209P >1000
(Staphylococcus aureus 209P)(Staphylococcus aureus 209P)
枯草杆菌 >1000Bacillus subtilis >1000
(Bacillus subtilis)(Bacillus subtilis)
胞变菌素从其理化性质上看属于肽类抗生素。由于在此以前尚未发现过肽类抗生素中有对黄单胞菌属的细菌具有特异的强生长抑制作用的物质,由此可以推断胞变菌素是一种新抗生素。Cytovaricins belong to peptide antibiotics in terms of their physical and chemical properties. Since no peptide antibiotic has been found to have a specific and strong growth inhibitory effect on bacteria of the genus Xanthomonas before, it can be inferred that cytotaxin is a new antibiotic.
综上所述,胞变菌素因对黄单胞菌属的细菌显示出强生长抑制功能,故而将可望被用作为农业用抗生素。To sum up, varicosin is expected to be used as an agricultural antibiotic because it exhibits a strong growth inhibitory function against bacteria of the genus Xanthomonas.
制造例:Manufacturing example:
以葡萄糖2%、可溶性淀粉1%、肉汁浸膏0.1%、干酵母0.4%、大豆粉2.5%、食盐0.2%、磷酸二氢钾0.005%的配比制成培养基,将上述SR-44菌株(CGMCC-0092)接种于该培养基中,置于28℃振荡培养96小时。取其培养液25升,于PH=4的条件下用醋酸乙酯进行抽提。提取液经减压浓缩后,即得4.8g油状物,然后将该油状物置于200ml甲醇中,升温至60℃使其溶解后,再降至0℃使其结晶,经过滤、甲醇洗涤,即可得到400mg无色结晶体。The above SR-44 strain (CGMCC-0092) was inoculated in this medium, and cultured with shaking at 28°C for 96 hours. Take 25 liters of its culture solution and extract it with ethyl acetate under the condition of PH=4. After the extract was concentrated under reduced pressure, 4.8g of oil was obtained, and then the oil was placed in 200ml of methanol, heated to 60°C to dissolve it, then lowered to 0°C to crystallize, filtered and washed with methanol, that is 400mg of colorless crystals can be obtained.
将上述结晶体用高速液相色谱进行精制。色谱柱为核苷5C18,直 径为20mm,长度为250mm。溶剂选用甲醇∶水=8∶2,流速为6.0ml/分,压力为180Kg/cm2,在保留时间为12分钟时出现胞变菌素的活性峰。收集上述活性峰,减压浓缩直至除尽甲醇为止。过滤后沉淀用甲醇重结晶,即可得到150mg胞变菌素的无色结晶状纯品。The above-mentioned crystals were purified by high-speed liquid chromatography. The chromatographic column is nucleoside 5C 18 , with a diameter of 20 mm and a length of 250 mm. The solvent is methanol: water = 8: 2, the flow rate is 6.0ml/min, the pressure is 180Kg/cm 2 , and the activity peak of cytastatin appears at the retention time of 12 minutes. The above active peaks were collected and concentrated under reduced pressure until methanol was completely removed. After filtration, the precipitate was recrystallized with methanol to obtain 150 mg of pure cytastatin in the form of colorless crystals.
附图说明Description of drawings
图1为本发明所述的抗生素胞变菌素的紫外吸收光谱图。图2为抗生素胞变菌素的红外吸收光谱图。Fig. 1 is the ultraviolet absorption spectrogram of the antibiotic cytotaxin according to the present invention. Fig. 2 is an infrared absorption spectrum diagram of the antibiotic cytastatin.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN86100600.3A CN1022765C (en) | 1986-06-20 | 1986-06-20 | Preparation method of cell variety mycomycin of new antibiotic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN86100600.3A CN1022765C (en) | 1986-06-20 | 1986-06-20 | Preparation method of cell variety mycomycin of new antibiotic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN86100600A CN86100600A (en) | 1988-07-20 |
| CN1022765C true CN1022765C (en) | 1993-11-17 |
Family
ID=4801124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN86100600.3A Expired - Fee Related CN1022765C (en) | 1986-06-20 | 1986-06-20 | Preparation method of cell variety mycomycin of new antibiotic |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1022765C (en) |
-
1986
- 1986-06-20 CN CN86100600.3A patent/CN1022765C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN86100600A (en) | 1988-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1007266B (en) | Method for making medication of resistance to parositic disease | |
| CN1035320A (en) | The acylamino acid recemase, its production method and application | |
| EP0547898B1 (en) | Microbial process for the production of trans-4-hydroxy-L-proline | |
| CN1030470C (en) | Preparation method of new antibiotic aureonucleomycin | |
| CN1043786C (en) | A kind of preparation method of new antibacterial compound | |
| CN1230182A (en) | Process for producing cyclodepsipeptide compounds and novel cyclodepsipeptide | |
| CN1161455C (en) | Bacterial strain and production method for producing a large amount of ε-poly-L-lysine | |
| US20070142424A1 (en) | Process for producing tacrolimus (FK-506) using vegetable oil as sole source of carbon | |
| CN1320099C (en) | Method for preparing epsilon-polylysine and salts thereof by using northern sporotrichum PL 6-3 | |
| CN1022765C (en) | Preparation method of cell variety mycomycin of new antibiotic | |
| CN1109687C (en) | Macrolides with antitumor activity | |
| JP2583554B2 (en) | New substance DC-107 | |
| JPS6310797A (en) | Antibiotic F-0769 | |
| JP2592468B2 (en) | Benanomycins A and B, novel antibiotics and their production | |
| JPH05310766A (en) | Novel antibiotic MI481-42F4-A and method for producing the same | |
| CN1095418A (en) | Produce 6 β, 14 alpha-dihydroxy-s-4-androstene-3, the method for 17-diketone | |
| CN86104124A (en) | Preparation method of new antibiotic SR-1223 | |
| FR2463618A1 (en) | NOVEL ANTIBIOTIC AMINOGLYCOSIDE AND ITS PRODUCTION | |
| CN1037539A (en) | The manufacture method of new antitumor antibiotic C-1027 | |
| JPH06312997A (en) | Ko-8119 substance and its production | |
| CN1034580A (en) | The manufacture method of a kind of antiparasitic new antibiotic and its esters | |
| CN86106265A (en) | Method for producing mildew mycin | |
| JPS63280073A (en) | Novel antibiotic yp-02978l-c and production thereof | |
| CN1014673B (en) | Anti-biotic 6270 process for its production, and its use as anticoccidiosis agent and feed additive | |
| JPS6257179B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |